ReviewKidney diseases (Basel, Switzerland)2020
Functional MRI as a Tool for Evaluating Interstitial Fibrosis and Prognosis in Kidney Disease.
Review in Kidney diseases (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Virtual MR elastography with diffusion-weighted imaging to evaluate chronic kidney disease fibrosis and dysfunction.Radiology advances · 2026Article
- Diffusion kurtosis imaging for detecting renal functional changes in glomerulonephritis: a longitudinal experimental study.BMC medical imaging · 2026Article
- Non-invasive assessment techniques for renal fibrosis: advances and perspectives.Renal failure · 2025Review
- Utility of the combination of IVIM-DWI MRI and baseline eGFR for identifying a high risk of chronic kidney disease progression.Frontiers in medicine · 2025Article
- AI-based segmentation of renal enhanced CT images for quantitative evaluate of chronic kidney disease.Scientific reports · 2024Article
- Native T1-mapping as a predictor of progressive renal function decline in chronic kidney disease patients.BMC nephrology · 2024Article
- Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets.Journal of clinical medicine · 2024Review
- Current progress in artificial intelligence-assisted medical image analysis for chronic kidney disease: A literature review.Computational and structural biotechnology journal · 2023Review
- Evaluation of Renal Fibrosis by Mapping Histology and Magnetic Resonance Imaging.Kidney diseases (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney fibrosis is a key driver of progression of kidney diseases. Renal biopsies remain the gold-standard approach to specifically diagnose and stage renal fibrosis at present. However, there is a lack of multi-dimensional pictures showing renal function, histology, and imaging of the fibrotic kidney. SUMMARY: Magnetic resonance imaging (MRI) strategies have been rapidly evolving during the past couple of decades, especially driven by advances in technology. Recently, several pioneer and remarkable studies demonstrated that advanced functional MRI (fMRI) tools could be useful for the evaluation of kidney fibrosis and progression, which provides more opportunities to benefit from the significant value of fMRI tools for clinical implementation. KEY MESSAGES: fMRI will be a novel approach to evaluate interstitial fibrosis and prognosis in kidney disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.